Owlet (OWLT) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Owlet Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Owlet is: No Data: Cannot be evaluated.

Competitive Comparison of Owlet's Risk Assessment

For the Medical Devices subindustry, Owlet's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Owlet's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Owlet's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Owlet's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Owlet (NYSE:OWLT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Owlet Risk Assessment Related Terms

Thank you for viewing the detailed overview of Owlet's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Owlet Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Owlet Inc (NYSE:OWLT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2940 West Maple Loop Drive, Suite 203, Lehi, UT, USA, 84043

Website

https://www.owletcare.com

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

Executives

Jonathan Harris	officer: President & CRO	3000 CLEARVIEW WAY, SAN MATEO CA 94402
Kurt Workman	director, officer: Chief Executive Officer	C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Kathryn R. Scolnick	officer: Chief Financial Officer	3300 N ASHTON BLVD, STE 300, LEHI UT 84043
Marc F Stoll	director	C/O ARISTA NETWORKS, INC., 5453 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054
Melissa Gonzales	director	C/O OWLET, INC., 3300 NORTH ASHTON BOULEVARD, SUITE 300, LEHI UT 84043
Jason Knafel	director	514 HIGH STREET, PALO ALTO CA 94301
Eclipse Early Growth Fund I, L.p.	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Early Growth Gp I, Llc	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Trilogy Equity Partners, Llc	10 percent owner	155 108TH AVE NE, SUITE 400, BELLEVUE WA 98004
Michael P. Abbott	director, officer: President	C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Nathaniel Yoo	officer: Chief Accounting Officer	C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Eclipse Continuity Fund I, L.p.	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Zane M Burke	director	C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
John C. Kim	director	C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Amy Nam Mccullough	director	C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043